Opko Health (Israel) Valuation

OPK -- Israel Stock  

ILS 860.50  0.60  0.07%

Opko Health holds recent Real Value of S706.1 per share. The prevailing price of the company is S860.5. At this time the company appears to be overvalued. Macroaxis determines value of Opko Health from analyzing the company fundamentals such as Shares Outstanding of 559.83M, Return On Equity of (8.42)% and Operating Margin of (16.29)% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we support investing in undervalued entities and to dispose of overvalued entities since at some point stocks prices and their ongoing real values will merge together.
Overvalued
April 22, 2019
860.50
Market Value
694.52
Downside
706.10
Real Value
947.21
Upside
Opko Health is very steady asset. Calculation of real value of Opko Health is based on 2 months time horizon. Increasing Opko Health time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Horizon     30 Days    Login   to change
Opko Health is considered to be number one stock in price to book category among related companies. It is considered to be number one stock in beta category among related companies totaling about  0.01  of Beta per Price to Book. The ratio of Price to Book to Beta for Opko Health is roughly  164.87 
Additionally take a look at Your Equity Center. Please also try Focused Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Search macroaxis.com